Case Reports
[Clinical application of NK 631 to head-and-neck cancers (author's transl)]
[Article in
Japanese]
- PMID: 84881
Item in Clipboard
Case Reports
[Clinical application of NK 631 to head-and-neck cancers (author's transl)]
[Article in
Japanese]
Jpn J Antibiot.
1979 Jan.
Abstract
NK 631, a new antibiotic of bleomycin analogue, was applied to the treatment of 15 patients with head-and-neck cancers. The results obtained were slightly better than bleomycin-treated cases. For the side effect of NK 631, there were no lung disorders in all patients.
Similar articles
-
[Primary effect of NK 631 against head-and-neck cancers (author's transl)].Jpn J Antibiot. 1979 Jan;32(1):106-14. Jpn J Antibiot. 1979. PMID: 84880 Japanese. No abstract available.
-
[Clinical experiences with pepleomycin (NK 631) (author's transl)].Jpn J Antibiot. 1978 Nov;31(11):659-63. Jpn J Antibiot. 1978. PMID: 83402 Japanese. No abstract available.
-
[Clinical effects of NK 631 (pepleomycin) against malignant tumors of the head and neck (author's transl)].Jpn J Antibiot. 1979 Jul;32(7):751-5. Jpn J Antibiot. 1979. PMID: 90743 Japanese.
-
[The role of chemotherapy in squamous cell cancer of the head and neck (author's transl)].HNO. 1981 Jul;29(7):225-39. HNO. 1981. PMID: 7021487 Review. German.
-
Current status of American studies with bleomycin.Prog Biochem Pharmacol. 1976;11:158-71. Prog Biochem Pharmacol. 1976. PMID: 63960 Review. No abstract available.